Azathioprine sodium

硫唑嘌呤钠

Report date: 2022/08/29 20:00:24
NME

Base Information

Drug NameAzathioprine sodium
Drug Alias Name硝基咪唑硫嘌呤钠咪唑硫嘌呤钠Imuran
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHypoxanthine-guanine phosphoribosyltransferase inhibitors
TargetsHypoxanthine-guanine phosphoribosyltransferase
Therapy Area/IndicationsRejection of renal transplantationArthritis, Rheumatoid
Global Approved IndicationsRejection of renal transplantationArthritis, Rheumatoid
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1974/07/19
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesSebela Ireland Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCasper Pharma Llc
Active IndicationsN/A
Inactive IndicationsRejection of renal transplantationArthritis, Rheumatoid

Other Information

ATC CodeL04AX01
Related LinksWikipediaDrugBankKEGG